Loading...
NPI 1023199601 · Annapolis, MD · Ambulatory Surgical Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Anne Arundel Urological Surgery Center LLC is a ambulatory surgical clinic/center provider located in Annapolis, Maryland. This profile covers 32 Medicare and 3 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Anne Arundel Urological Surgery Center LLC |
| Address | 600 Ridgely Ave Ste 130 |
| City | Annapolis |
| State | MD |
| ZIP | 21401 |
| Taxonomy | Ambulatory Surgical Clinic/Center |
| NPI Enumerated | October 18, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $2.9M |
| Medicaid | $-2740 |
ANNE ARUNDEL UROLOGICAL SURGERY CENTER LLC bills predominantly as an Ambulatory Surgical Clinic/Center and its Medicare mix ($2.9M total Medicare revenue) is concentrated in procedural urology. The top codes on the Medicare side are heavy on endoscopic bladder and ureteral work (52000, 52356, 52332), stone management (50590, 52352), transurethral prostate procedures (52648, 52601), and device/implant services (64590, 64561, C9740), consistent with a high-volume urology surgery center rather than a general outpatient clinic.
Revenue concentration on Medicare is meaningful: the provider's top 3 Medicare codes (52000, 64590, 64561) account for 34.7% of its total Medicare revenue. Those codes individually generate $435.5K (52000, 15.2%), $309.8K (64590, 10.8%), and $247.5K (64561, 8.6%), indicating a concentrated set of high-value procedures driving over one-third of Medicare income.
The practice is a clear national outlier on multiple cystoscopic and stone-procedure codes, signaling a dominant procedural footprint for specific services. For example, 52000 ranks #4 of 8548 providers nationally (100th percentile; extreme outlier), 52356 ranks #11 of 3090 (100th percentile; extreme outlier), and 52332 ranks #37 of 3938 (99th percentile; extreme outlier), showing substantially higher-than-typical national volumes for cystoscopy/ureteroscopy work.
Device and implant services are an important part of the business mix but are less extreme in national standing than the cystoscopy volumes. Codes for neurostimulator and sacral electrode work such as 64590 ($309.8K revenue, rank #162 of 561, 68th percentile; typical, unremarkable volume) and 64561 ($247.5K revenue, rank #70 of 564, 87th percentile; typical, unremarkable volume) indicate a meaningful implant program without the same extreme outlier status seen in endoscopic procedures.
Several additional Medicare codes further underscore specialized high-volume services rather than isolated spikes. Examples include 55700 ($224.6K, rank #13 of 4425, 100th percentile; extreme outlier), 50590 ($117.6K, rank #19 of 1163, 98th percentile; extreme outlier), and 51700 ($20.6K, rank #3 of 2936, 100th percentile; extreme outlier), collectively pointing to a suite of recurrent procedural lines—cystoscopy, stone treatment, and related bladder therapies—at volumes far above typical national peers.
Payer mix is effectively single-payer in practice: Medicare dominates with $2.9M in lifetime Medicare revenue while Medicaid activity is negligible and net negative at $-2.7K. This wide gap makes the center functionally Medicare-dependent for scale and suggests Medicaid is not a material revenue stream for this entity.
The Medicaid footprint is small and anomalous: the provider's top 3 Medicaid codes (52000, G8918, G8907) are reported to account for 100.0% of its Medicaid revenue, yet the Medicaid total is $-2.7K. Two Medicaid billing lines show negative paid amounts (G8918, $-1.4K; G8907, $-2.4K), which drive the net negative Medicaid figure and imply payment adjustments or reversals rather than meaningful positive Medicaid reimbursement; in-state the 52000 Medicaid rank is #6 of 21 (75th percentile), indicating modest state-level volume when present.
The NPI has been enumerated since 2006-10-18 (~20 years ago), so this is an established facility with a long operating history. Combined with repeated high national ranks on key urology procedure codes, tenure plus the concentrated Medicare case mix point to a mature, specialized ambulatory urology surgery center with sustained referral volume for cystoscopic, stone, prostate, and implantable-device procedures.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
32 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 2,070 | $210 | $435.5K |
| 64590 | The provider inserts or replaces a peripheral, sacral, or gastric neurostimulator pulse generator or receiver. The system is one that requires surgical creation of a pocket for placement and that… | 20 | $14,750 | $309.8K |
| 64561 | The provider, under imaging guidance, implants electrodes around nerves in the sacral region to reduce the pain along the path of the nerve. | 70 | $3,810 | $247.5K |
| 55700 | Code deleted December 31, 2025. | 350 | $640 | $224.6K |
| 52356 | The provider performs a cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the urethra and into… | 110 | $1,730 | $193.3K |
| C9740 | Cystourethroscopy, with insertion of transprostatic implant; 4 or more implants | 30 | $5,510 | $181.7K |
| 55874 | Under imaging guidance, the provider inserts a needle through the perineum, the area between the anus and the scrotum, and injects one or more biodegradable materials, i.e., material that decomposes… | 60 | $2,720 | $155K |
| 52648 | Transurethral resection of the prostate is performed in cases of BPH (benign prostate hyperplasia) which commonly occurs in middle–aged and elderly men, often causing lower urinary symptoms, with… | 80 | $1,730 | $139.9K |
| 50590 | Extracorporeal shock wave lithotripsy (ESWL) is a procedure used to destroy calculus (kidney stones) in the kidneys and ureters. | 100 | $1,140 | $117.6K |
| 52310 | The provider performs a simple cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the urethra… | 140 | $640 | $88K |
Showing 1–10 of 32
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 32 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
32 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| C9740 | 7 | 20 | 30 | $5,500 | $225.7K |
| 64590 | 6 | 20 | 20 | $7,550 | $151.1K |
| 64561 | 4 | 30 | 40 | $2,550 | $104.4K |
| J0585 | 19 | 80 | 8,130 | $1 | $49K |
| 55874 | 1 | 20 | 20 | $1,890 | $43.5K |
| 50590 | 2 | 30 | 30 | $800 | $32.2K |
| 52648 | 2 | 40 | 20 | $1,160 | $31.4K |
| 52601 | 8 | 40 | 20 | $1,260 | $29.1K |
| 52000 | 1 | 200 | 120 | $140 | $25.8K |
| 52356 | 2 | 100 | 20 | $900 | $25.3K |
Showing 1–10 of 32
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
3 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 260 | $1 | $1K |
| G8918 | Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis | 10 | $-120 | $-1440 |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 40 | $-60 | $-2360 |
How this provider's Medicaid billing volume and revenue compare to other Maryland providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Maryland median
3 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| G8918 | Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis | 50 | 50 | 90 | $70 | $28.2K |
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 6 | 20 | 60 | $50 | $23.4K |
| G8907 | Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer… | 65 | 90 | 110 | $30 | $11.9K |
Other providers in the same ZIP code as Anne Arundel Urological Surgery Center LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.